4-[3-[4,6-bis(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-2-phenylquinazoline;2-(9,9-dimethylfluoren-2-yl)-4-phenyl-6-(4-phenylphenyl)-1,3,5-triazine;2-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]benzo[c][1,5]naphthyridine;2-phenanthren-3-yl-4-(3-phenylphenyl)-6-[4-(4-phenylphenyl)phenyl]-1,3,5-triazine

C163H110N16 — CID 165096089

About 4-[3-[4,6-bis(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-2-phenylquinazoline;2-(9,9-dimethylfluoren-2-yl)-4-phenyl-6-(4-phenylphenyl)-1,3,5-triazine;2-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]benzo[c][1,5]naphthyridine;2-phenanthren-3-yl-4-(3-phenylphenyl)-6-[4-(4-phenylphenyl)phenyl]-1,3,5-triazine

4-[3-[4,6-bis(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-2-phenylquinazoline;2-(9,9-dimethylfluoren-2-yl)-4-phenyl-6-(4-phenylphenyl)-1,3,5-triazine;2-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]benzo[c][1,5]naphthyridine;2-phenanthren-3-yl-4-(3-phenylphenyl)-6-[4-(4-phenylphenyl)phenyl]-1,3,5-triazine (PubChem CID 165096089) has the molecular formula C163H110N16 and a molecular weight of 2292.78 g/mol. Its IUPAC name is 4-[3-[4,6-bis(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-2-phenylquinazoline;2-(9,9-dimethylfluoren-2-yl)-4-phenyl-6-(4-phenylphenyl)-1,3,5-triazine;2-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]benzo[c][1,5]naphthyridine;2-phenanthren-3-yl-4-(3-phenylphenyl)-6-[4-(4-phenylphenyl)phenyl]-1,3,5-triazine.

Molecular Properties

• Compound Name: 4-[3-[4,6-bis(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-2-phenylquinazoline;2-(9,9-dimethylfluoren-2-yl)-4-phenyl-6-(4-phenylphenyl)-1,3,5-triazine;2-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]benzo[c][1,5]naphthyridine;2-phenanthren-3-yl-4-(3-phenylphenyl)-6-[4-(4-phenylphenyl)phenyl]-1,3,5-triazine
• PubChem CID: 165096089
• Molecular Formula: C163H110N16
• Molecular Weight: 2292.78 g/mol
• Exact Mass: 2290.91
• IUPAC Name: 4-[3-[4,6-bis(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-2-phenylquinazoline;2-(9,9-dimethylfluoren-2-yl)-4-phenyl-6-(4-phenylphenyl)-1,3,5-triazine;2-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]benzo[c][1,5]naphthyridine;2-phenanthren-3-yl-4-(3-phenylphenyl)-6-[4-(4-phenylphenyl)phenyl]-1,3,5-triazine
• SMILES: CC1(C)c2ccccc2-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc(-c5ccccc5)cc4)n3)cc21.c1ccc(-c2ccc(-c3ccc(-c4nc(-c5cccc(-c6ccccc6)c5)nc(-c5ccc6ccc7ccccc7c6c5)n4)cc3)cc2)cc1.c1ccc(-c2ccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-c4cccc(-c5nc(-c6ccccc6)nc6ccccc56)c4)n3)cc2)cc1.c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-c4ccc5ncc6ccccc6c5n4)c3)n2)cc1
• InChI: InChI=1S/C47H31N5.C47H31N3.C36H27N3.C33H21N5/c1-4-13-32(14-5-1)34-23-27-37(28-24-34)45-50-46(38-29-25-35(26-30-38)33-15-6-2-7-16-33)52-47(51-45)40-20-12-19-39(31-40)43-41-21-10-11-22-42(41)48-44(49-43)36-17-8-3-9-18-36;1-3-10-32(11-4-1)34-18-20-35(21-19-34)36-22-27-39(28-23-36)45-48-46(41-16-9-15-40(30-41)33-12-5-2-6-13-33)50-47(49-45)42-29-26-38-25-24-37-14-7-8-17-43(37)44(38)31-42;1-36(2)31-16-10-9-15-29(31)30-22-21-28(23-32(30)36)35-38-33(26-13-7-4-8-14-26)37-34(39-35)27-19-17-25(18-20-27)24-11-5-3-6-12-24;1-3-10-22(11-4-1)31-36-32(23-12-5-2-6-13-23)38-33(37-31)25-16-9-15-24(20-25)28-18-19-29-30(35-28)27-17-8-7-14-26(27)21-34-29/h1-31H;1-31H;3-23H,1-2H3;1-21H
• InChIKey: XNMJSVYFKYDIPY-UHFFFAOYSA-N
• XLogP: 40.15
• TPSA: 206.24 Ų
• H-Bond Acceptors: 16
• Rotatable Bonds: 21
• Heavy Atoms: 179
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2292.78
LogP ≤ 5	40.15
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	16

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 4-[3-[4,6-bis(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-2-phenylquinazoline;2-(9,9-dimethylfluoren-2-yl)-4-phenyl-6-(4-phenylphenyl)-1,3,5-triazine;2-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]benzo[c][1,5]naphthyridine;2-phenanthren-3-yl-4-(3-phenylphenyl)-6-[4-(4-phenylphenyl)phenyl]-1,3,5-triazine?

The IUPAC name of 4-[3-[4,6-bis(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-2-phenylquinazoline;2-(9,9-dimethylfluoren-2-yl)-4-phenyl-6-(4-phenylphenyl)-1,3,5-triazine;2-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]benzo[c][1,5]naphthyridine;2-phenanthren-3-yl-4-(3-phenylphenyl)-6-[4-(4-phenylphenyl)phenyl]-1,3,5-triazine (CID 165096089) is 4-[3-[4,6-bis(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-2-phenylquinazoline;2-(9,9-dimethylfluoren-2-yl)-4-phenyl-6-(4-phenylphenyl)-1,3,5-triazine;2-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]benzo[c][1,5]naphthyridine;2-phenanthren-3-yl-4-(3-phenylphenyl)-6-[4-(4-phenylphenyl)phenyl]-1,3,5-triazine.

What is the SMILES notation for 4-[3-[4,6-bis(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-2-phenylquinazoline;2-(9,9-dimethylfluoren-2-yl)-4-phenyl-6-(4-phenylphenyl)-1,3,5-triazine;2-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]benzo[c][1,5]naphthyridine;2-phenanthren-3-yl-4-(3-phenylphenyl)-6-[4-(4-phenylphenyl)phenyl]-1,3,5-triazine?

The canonical SMILES for 4-[3-[4,6-bis(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-2-phenylquinazoline;2-(9,9-dimethylfluoren-2-yl)-4-phenyl-6-(4-phenylphenyl)-1,3,5-triazine;2-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]benzo[c][1,5]naphthyridine;2-phenanthren-3-yl-4-(3-phenylphenyl)-6-[4-(4-phenylphenyl)phenyl]-1,3,5-triazine is CC1(C)c2ccccc2-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc(-c5ccccc5)cc4)n3)cc21.c1ccc(-c2ccc(-c3ccc(-c4nc(-c5cccc(-c6ccccc6)c5)nc(-c5ccc6ccc7ccccc7c6c5)n4)cc3)cc2)cc1.c1ccc(-c2ccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-c4cccc(-c5nc(-c6ccccc6)nc6ccccc56)c4)n3)cc2)cc1.c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-c4ccc5ncc6ccccc6c5n4)c3)n2)cc1.

What is the InChIKey of 4-[3-[4,6-bis(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-2-phenylquinazoline;2-(9,9-dimethylfluoren-2-yl)-4-phenyl-6-(4-phenylphenyl)-1,3,5-triazine;2-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]benzo[c][1,5]naphthyridine;2-phenanthren-3-yl-4-(3-phenylphenyl)-6-[4-(4-phenylphenyl)phenyl]-1,3,5-triazine?

The InChIKey is XNMJSVYFKYDIPY-UHFFFAOYSA-N. The full InChI is InChI=1S/C47H31N5.C47H31N3.C36H27N3.C33H21N5/c1-4-13-32(14-5-1)34-23-27-37(28-24-34)45-50-46(38-29-25-35(26-30-38)33-15-6-2-7-16-33)52-47(51-45)40-20-12-19-39(31-40)43-41-21-10-11-22-42(41)48-44(49-43)36-17-8-3-9-18-36;1-3-10-32(11-4-1)34-18-20-35(21-19-34)36-22-27-39(28-23-36)45-48-46(41-16-9-15-40(30-41)33-12-5-2-6-13-33)50-47(49-45)42-29-26-38-25-24-37-14-7-8-17-43(37)44(38)31-42;1-36(2)31-16-10-9-15-29(31)30-22-21-28(23-32(30)36)35-38-33(26-13-7-4-8-14-26)37-34(39-35)27-19-17-25(18-20-27)24-11-5-3-6-12-24;1-3-10-22(11-4-1)31-36-32(23-12-5-2-6-13-23)38-33(37-31)25-16-9-15-24(20-25)28-18-19-29-30(35-28)27-17-8-7-14-26(27)21-34-29/h1-31H;1-31H;3-23H,1-2H3;1-21H.

What are the key properties of 4-[3-[4,6-bis(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-2-phenylquinazoline;2-(9,9-dimethylfluoren-2-yl)-4-phenyl-6-(4-phenylphenyl)-1,3,5-triazine;2-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]benzo[c][1,5]naphthyridine;2-phenanthren-3-yl-4-(3-phenylphenyl)-6-[4-(4-phenylphenyl)phenyl]-1,3,5-triazine?

4-[3-[4,6-bis(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-2-phenylquinazoline;2-(9,9-dimethylfluoren-2-yl)-4-phenyl-6-(4-phenylphenyl)-1,3,5-triazine;2-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]benzo[c][1,5]naphthyridine;2-phenanthren-3-yl-4-(3-phenylphenyl)-6-[4-(4-phenylphenyl)phenyl]-1,3,5-triazine has a molecular weight of 2292.78 g/mol, XLogP of 40.15, 21 rotatable bonds, 0 hydrogen bond donors, and 16 hydrogen bond acceptors.

Where does this data come from?

All data for 4-[3-[4,6-bis(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-2-phenylquinazoline;2-(9,9-dimethylfluoren-2-yl)-4-phenyl-6-(4-phenylphenyl)-1,3,5-triazine;2-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]benzo[c][1,5]naphthyridine;2-phenanthren-3-yl-4-(3-phenylphenyl)-6-[4-(4-phenylphenyl)phenyl]-1,3,5-triazine is sourced from PubChem (CID 165096089), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).